Metagenomics for Detection and Discovery of Viruses Associated with Acute Gastroenteritis in Mexico |
Mexico |
Drug and Diagnostics Development |
|
|
Identification of Viruses in an Asthma Cohort |
United States |
Chronic Respiratory Disease, Drug and Diagnostics Development |
|
|
Metagenomics for Identification of Infectious Triggers of KLS |
United States |
Drug and Diagnostics Development |
|
|
Virus Detection Using Microarrays and Characterization of a Novel Cardiovirus |
United States |
Drug and Diagnostics Development |
|
|
To Discover and Characterize Novel Viruses in Cancer |
United States |
Infectious Disease, Cancer/Oncology |
|
|
Viral Discovery in Human and Animal Samples |
Rwanda; Uganda; Tanzania; Cameroon; Congo (Kinshasa); Congo (Brazzaville); Gabon; China; Bangladesh; Nepal; Cambodia; Indonesia; Viet Nam; Laos; Malaysia; Thailand; Mexico; Bolivia; Brazil; Peru |
Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development |
|
|
Using Pan-Pathogen Microarrays and Deep Sequencing to Search for the Cause of Southern Tick-Associated Rash Illness (STARI) |
United States |
Zoonosis, Emerging Disease, and Drug Resistance |
|
|
A Rapid Pan-Viral Microarray Diagnostic for Category A-C Biodefense Pathogens |
Uganda; India; Mexico |
Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development |
|
|
Comprehensive Diagnostics for Viral Encephalitis/Meningitis |
United States |
Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development |
|
|
Multiplexed Viral and Cytokine Response Assays Using NanoString Technology |
United States |
Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development |
|
|
Pathogen Discovery in PREDICT Human and Wildlife samples to Detect and Identify Viruses Present, Both Known and Novel |
China; Bangladesh; Indonesia; Malaysia; Mexico; Brazil; Colombia |
Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development |
|
|
Clin 0004 Characterization of Viral Hemorrhagic Fevers of Unknown Origin |
Cameroon; Central African Republic; Congo (Kinshasa); Congo (Brazzaville); Gabon |
Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development |
|
|
Clin 0003 Identification and Characterization of a Putative Novel Poxvirus in the DRC |
Congo (Kinshasa) |
Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development |
|
|
CCD Study- RNA Sequencing |
United States |
Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development |
|
|
Pathogen characterization and discovery by deep sequencing of two major vectors associated with Lyme disease and other tickborne infections |
United States |
Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development |
|
|
Establishing a Core Facility for Virus Detection and Discovery |
United States |
Drug and Diagnostics Development, Epidemiology and Surveillance |
|
|
Comprehensive Diagnostics for Viral Encephalitis/Meningitis |
United States |
Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development |
|
|
Broad Detection of Infectious Agents in Blood by Microarrays and Deep Sequencing |
United States |
Infectious Disease, Drug and Diagnostics Development |
|
|
Whole Blood/Serum Samples from Patients with Hepatitis |
United States |
Infectious Disease, Drug and Diagnostics Development |
|
|
Tissue Biopsy Samples from Head and Neck Cancers |
Japan |
Cancer/Oncology, Drug and Diagnostics Development |
|
|
Serological prevalence of viral hemorrhagic fevers in Equatorial Africa |
Cameroon; Central African Republic; Congo (Kinshasa); Congo (Brazzaville); Equatorial Guinea; Gabon |
Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance |
|
|
Development of the infant gastrointestinal virome and shedding of oral polio and rotavirus vaccines in Bangladeshi and US infants |
Bangladesh |
Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development, Newborn and Infant Health |
|
|
Metabiota - Viral Surveillance for the PREDICT Program 20150410 |
Rwanda; Uganda; Tanzania; Cameroon; Congo (Kinshasa); Congo (Brazzaville); Gabon; China; Bangladesh; Nepal; Cambodia; Indonesia; Viet Nam; Laos; Malaysia; Thailand; Mexico; Bolivia; Brazil; Peru |
Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development |
|
|
Identification of Signaling Pathways Associated with Lyme Disease |
United States |
Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development |
|
|
Real-Time Unbiased Pathogen Detection in Febrile Illnesses by Nanopore Sequencing |
Congo (Kinshasa); Congo (Brazzaville); Brazil |
Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development |
|
|
Pathogen discovery and epidemiology in tick vectors associated with Lyme-like diseases |
United States |
Zoonosis, Emerging Disease, and Drug Resistance |
|
|
Simcere Surpi eval project |
United States |
Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development |
|
|
Identification of diagnostic and prognostic host biomarkers of Zika virus infection by transcriptome profiling |
United States |
|
|
|
Real-Time Detection of Bloodborne Pathogens by Unbiased Nanopore Sequencing 20150506 |
United States |
Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development |
|
|
Pan-Genomic Approaches for Comprehensive Blood Screening of Novel or Emerging Infectious Agents |
United States |
Infectious Disease |
|
|
A Combined Pathogen-Host Sequencing Assay for Diagnosis of Lyme and Other Tickborne Infections |
United States |
Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development |
|
|